• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对新冠病毒的先天性免疫的免疫疗法

Immunotherapy approaches on innate immunity for SARS-Cov-2.

作者信息

Arslan B A, Timucin A C

出版信息

Acta Virol. 2020;64(4):389-395. doi: 10.4149/av_2020_401.

DOI:10.4149/av_2020_401
PMID:32985199
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused fatal outbreaks of pneumonia. The similarity of S protein of SARS-CoV-2 with SARS-CoV and RaTG13 is about 76% and 97%, respectively. Also its potential receptor-binding domain (RBD) shows similarity with approximately 74% and 90.1% for SARS-CoV and RaTG13, respectively. SARS-CoV-2 has been shown to use the SARS-CoV receptor ACE2 for entry and serine protease TMPRSS2 for S protein priming. Sialic acids are primarily expressed by vertebrates and some microbial pathogens improving the ability to avoid immune system of vertebrate host. Interactions of sialic acid-binding Ig-like lectins (Siglecs) with their ligands play an important role in modulating immune cell function activities as their regulators. Therefore, while Siglecs help immune cells to distinguish between self and non-self, non-self ligands of some sialylated pathogens can recognize Siglecs and reduce immune cell responses or escape from immune surveillance. In this review, innate immunity in SARS-Cov-2 infection was discussed through Siglecs, especially Siglec-7, Siglec-3, NKG2A and neuraminidases. Keywords: SARS-Cov-2; siglecs; NK cells; NKG2A; neuraminidases.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已引发致命的肺炎疫情。SARS-CoV-2的S蛋白与SARS-CoV和RaTG13的相似度分别约为76%和97%。其潜在的受体结合域(RBD)与SARS-CoV和RaTG13的相似度分别约为74%和90.1%。已证明SARS-CoV-2利用SARS-CoV的受体血管紧张素转换酶2(ACE2)进入细胞,并利用丝氨酸蛋白酶TMPRSS2对S蛋白进行启动。唾液酸主要由脊椎动物和一些微生物病原体表达,可提高其逃避脊椎动物宿主免疫系统的能力。唾液酸结合免疫球蛋白样凝集素(Siglecs)与其配体的相互作用作为调节剂在调节免疫细胞功能活动中起重要作用。因此,虽然Siglecs有助于免疫细胞区分自我和非自我,但一些唾液酸化病原体的非自我配体可以识别Siglecs并降低免疫细胞反应或逃避免疫监视。在本综述中,通过Siglecs,特别是Siglec-7、Siglec-3、NKG2A和神经氨酸酶,探讨了SARS-Cov-2感染中的固有免疫。关键词:SARS-Cov-2;Siglecs;自然杀伤细胞;NKG2A;神经氨酸酶。

相似文献

1
Immunotherapy approaches on innate immunity for SARS-Cov-2.针对新冠病毒的先天性免疫的免疫疗法
Acta Virol. 2020;64(4):389-395. doi: 10.4149/av_2020_401.
2
Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.严重 COVID-19 感染的常见决定因素可以用 SARS-CoV-2 分泌糖蛋白与 CD33 相关的 Siglec 家族成员 Siglec-3 和 Siglec-5/14 的相互作用来解释。
Med Hypotheses. 2020 Nov;144:110168. doi: 10.1016/j.mehy.2020.110168. Epub 2020 Aug 7.
3
Sialic acids siglec interaction: a unique strategy to circumvent innate immune response by pathogens.唾液酸与唾液酸结合免疫球蛋白样凝集素的相互作用:病原体规避先天性免疫反应的独特策略。
Indian J Med Res. 2013 Nov;138(5):648-62.
4
Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.单细胞分析 SARS-CoV-2 受体 ACE2 和刺突蛋白在人心脏中对蛋白酶的预激活表达。
Cardiovasc Res. 2020 Aug 1;116(10):1733-1741. doi: 10.1093/cvr/cvaa191.
5
SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.SARS-CoV-2 进化适应宿主进入和识别病毒-宿主相互作用中受体 O-乙酰神经氨酸糖基化。
Int J Mol Sci. 2020 Jun 26;21(12):4549. doi: 10.3390/ijms21124549.
6
Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.唾液酸结合免疫球蛋白样凝集素(Siglecs):唾液酸结合免疫球蛋白型凝集素的进化之旅。
Dev Comp Immunol. 2018 Sep;86:219-231. doi: 10.1016/j.dci.2018.05.008. Epub 2018 May 8.
7
Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.尼罗罗非鱼中性粒细胞中3种siglec样蛋白的发现、表达及其与B族链球菌唾液酸化荚膜多糖的相互作用
Mol Immunol. 2016 May;73:158-69. doi: 10.1016/j.molimm.2016.01.005. Epub 2016 Feb 1.
8
The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunity.唾液酸糖蛋白-Siglec 糖免疫检查点——提高固有和适应性抗肿瘤免疫的靶点。
Expert Opin Ther Targets. 2019 Oct;23(10):839-853. doi: 10.1080/14728222.2019.1667977. Epub 2019 Sep 23.
9
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.Siglec-9 抑制针对 SARS-CoV-2 的抗体依赖的自然杀伤细胞细胞毒性。
mBio. 2023 Feb 28;14(1):e0339322. doi: 10.1128/mbio.03393-22. Epub 2023 Feb 2.
10
Siglecs at the Host-Pathogen Interface.宿主-病原体界面上的 Siglecs。
Adv Exp Med Biol. 2020;1204:197-214. doi: 10.1007/978-981-15-1580-4_8.

引用本文的文献

1
Dataset of single nucleotide polymorphisms of immune-associated genes in patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者免疫相关基因单核苷酸多态性数据集。
PLoS One. 2023 Nov 16;18(11):e0287725. doi: 10.1371/journal.pone.0287725. eCollection 2023.
2
The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2.铁(III)和镍(II)与四齿硫代氨基脲的配合物。合成、实验、理论表征及对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗病毒作用。
J Mol Struct. 2021 Dec 15;1246:131166. doi: 10.1016/j.molstruc.2021.131166. Epub 2021 Jul 22.